Skip to main content
. Author manuscript; available in PMC: 2009 Aug 26.
Published in final edited form as: HIV Med. 2008 Sep 14;9(10):875–882. doi: 10.1111/j.1468-1293.2008.00640.x

Fig. 2.

Fig. 2

Nelfinavir and hydroxyl-tert-butylamide (M8) area under the plasma concentration–time curves (AUCs). (a) Antepartum and postpartum nelfinavir AUCs, second trimester (n = 4), to third trimester (n = 27) to postpartum (n = 22) in the same patients. The horizontal line indicates the 50th percentile AUC in non-pregnant adults (26 μg h/mL). (b) Antepartum and postpartum M8 AUCs, second trimester (n = 4), to third trimester (n = 27) to postpartum (n = 22) in the same patients.